Home	COPD (Chronic Obstructive Pulmonary Disease)  Predictive Treatment Tool  (Initial rough draft - 12/2003)
Patient's Spirometry: FEV1/FVC  > 70%FEV1/FVC  < 70%  FEV1 > 80% of predictedFEV1  >/= 50  but  <80%FEV1  >/= 30  but  <50%FEV1  <  30% of predicted (FEV1 based on Post-bronchodilator)
Chronic symptoms present ? (e.g. Cough, sputum production, or dypsnea): NoYes Clinical signs of right heart failure or respiratory failure: NoYes Frequent exacerbations: NoYes
Please check any that apply (if present) - acute changes:  Increased dyspnea   |  Increased sputum volume   | Increased sputum purulence
Current Medications (Please check all that apply):   Ipratropium: | Short-acting Beta-2 agonist (e.g. albuterol):   |  Theophylline (IV or po):  |  Long-acting Beta-2 agonist (e.g. Salmeterol): |   Corticosteroid (systemic):   |  Corticosteroid (inhaler):
Determine if a patient meets criteria for the following interventions:
General Guidelines:
Reference: Respir Care. 2001 Aug;46(8):798-825.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary.   Pauwels RA, Buist AS, Ma P, Jenkins CR, Hurd SS; GOLD Scientific Committee.